a decreasing trendP > 0.05
A decreasing trend was also observed in the spleen following rosiglitazone treatment ( P > 0.05, Fig. 10 C), while a significant reduction was detected in the blood ( P < 0.05, Fig. 10 C).
A decreasing trend was also observed in the spleen following rosiglitazone treatment ( P > 0.05, Fig. 10 C), while a significant reduction was detected in the blood ( P < 0.05, Fig. 10 C).